Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1645
This examiner grants 76% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18722030 | METHODS AND COMPOSITIONS OF TREATING BIOLFILM-RELATED DISEASES | Non-Final OA | UNIVERSITY OF ROCHESTER |
| 18261568 | Staphylococcus aureus Antigen-Based Nucleic Acid Vaccines | Final Rejection | University of Rochester |
| 17620633 | BACTERIA-ENGINEERED TO ELICIT ANTIGEN-SPECIFIC T-CELLS | Final Rejection | The Board of Trustees of the Leland Stanford Junior University |
| 18895960 | STRAINS, COMPOSITIONS AND METHODS OF USE | Non-Final OA | L'Oreal S.A. |
| 18684124 | COMPOSITIONS AND METHODS FOR GENERATING TICK IMMUNITY | Non-Final OA | Yale University |
| 18700490 | A Novel Poultry Salmonella Vaccine and Diagnostic Methodology to Control Foodborne Salmonellosis | Non-Final OA | THE PENN STATE RESEARCH FOUNDATION |
| 18683849 | GENETICALLY MODIFIED YEAST AND FERMENTATION PROCESSES FOR THE PRODUCTION OF LACTATE | Non-Final OA | CARGILL, INCORPORATED |
| 17785524 | Methods for Identifying Modulators of G Protein-Coupled Receptors | Final Rejection | University of Miami |
| 18721985 | Method for Preparing Outer Membrane Vesicles | Non-Final OA | GLAXOSMITHKLINE BIOLOGICALS SA |
| 18258842 | IRRADIATED WHOLE-CELL IMMUNOGENS OF ACINETOBACTER BAUMANNII | Non-Final OA | The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. |
| 18248120 | COMBINATION OF INHALED ANTIBODIES AND IMMUNOMODULATORY AGENTS FOR THE TREATMENT OR PREVENTION OF RESPIRATORY INFECTIONS | Non-Final OA | INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE) |
| 18162032 | Immunogenic Antigens | Non-Final OA | Longhorn Vaccines and Diagnostics, LLC |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy